Extension study of LUM001 in Alagille Syndrome paediatric patients.

• Research type

  Research Study

• Full title

  A Multicentre Extension Study to Evaluate the Long-Term Safety and Durability of the Therapeutic Effect of LUM001, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi), in the Treatment of Cholestatic Liver Disease in Pediatric Subjects with Alagille Syndrome.

• IRAS ID

  138752

• Contact name

  Richard Thompson

• Contact email

  richard.j.thompson@kcl.ac.uk

• Sponsor organisation

  Lumena Pharmaceuticals UK

• Eudract number

  2013-003832-54

• REC name

  London - Bloomsbury Research Ethics Committee

• REC reference

  13/LO/1600

• Date of REC Opinion

  28 Nov 2013

• REC opinion

  Further Information Favourable Opinion